<?xml version="1.0" encoding="UTF-8"?>
<ref id="ajh25238-bib-0025">
 <label>25</label>
 <mixed-citation publication-type="journal" id="ajh25238-cit-0025">
  <string-name>
   <surname>Martinelli</surname>
   <given-names>G</given-names>
  </string-name>, 
  <string-name>
   <surname>Oehler</surname>
   <given-names>VG</given-names>
  </string-name>, 
  <string-name>
   <surname>Papayannidis</surname>
   <given-names>C</given-names>
  </string-name>, et al. 
  <article-title>Treatment with PF‐04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study</article-title>. 
  <source xml:lang="en">Lancet Haematol</source>. 
  <year>2015</year>;
  <volume>2</volume>:
  <fpage>e339</fpage>‐
  <lpage>e346</lpage>.
  <pub-id pub-id-type="pmid">26688487</pub-id>
 </mixed-citation>
</ref>
